PNC Financial Services Group
DERM icon

PNC Financial Services Group’s Journey Medical DERM Stock Holding History

PNC Financial Services Group’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$192 Sell
41
-33
-45% -$256 ﹤0.01% 5038
2025
Q4 		$571 Buy
+74
New +$580 ﹤0.01% 4804

Other funds holding DERM

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.14B AUM 42.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PNC Financial Services Group's DERM Position: Q1 2026 in Review

PNC Financial Services Group reduced its Journey Medical (DERM) stake by 45% in Q1 2026, selling an estimated $256 and leaving 41 shares worth $192. The position accounts for ﹤0.01% of the portfolio, ranked #5038.

PNC Financial Services Group first reported a position in DERM in Q4 2025 and has held it in 2 quarters since. The position peaked at $571 in Q4 2025. 71 funds tracked by Wall St. Rank hold DERM as of Q1 2026.

  • PNC Financial Services Group held 41 shares of Journey Medical worth $192 as of Q1 2026.
  • PNC Financial Services Group sold 33 Journey Medical shares in Q1 2026, an estimated $256.
  • Journey Medical made up ﹤0.01% of PNC Financial Services Group's portfolio in Q1 2026, its #5038 holding.
  • PNC Financial Services Group first reported a position in Journey Medical in Q4 2025 and has held it in 2 quarters since.
  • PNC Financial Services Group's Journey Medical position peaked at $571 in Q4 2025.
  • 71 funds tracked by Wall St. Rank held Journey Medical as of Q1 2026.

Based on PNC Financial Services Group's 13F filing for Q1 2026, filed 8 May 2026.